Works matching AU Hébert, Vivien

Results: 14

Modifications of the Transcriptomic Profile of Autoreactive B Cells From Pemphigus Patients After Treatment With Rituximab or a Standard Corticosteroid Regimen.

Published in:

Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01794

By:

Hébert, Vivien;
Petit, Marie;
Maho-Vaillant, Maud;
Golinski, Marie-Laure;
Riou, Gaëtan;
Derambure, Céline;
Boyer, Olivier;
Joly, Pascal;
Calbo, Sébastien

Publication type:

Article

Major improvement of very severe alopecia areata in patients treated with the combination of baricitinib and low doses of corticosteroids: an eight-case series.

Published in:

Clinical & Experimental Dermatology, 2023, v. 48, n. 11, p. 1258, doi. 10.1093/ced/llad239

By:

Hébert, Vivien;
Joly, Pascal

Publication type:

Article

Agranulocytosis‐complicated DRESS with medullar HHV‐6 replication.

Published in:

Clinical Case Reports, 2020, v. 8, n. 10, p. 1928, doi. 10.1002/ccr3.3033

By:

Lehericey, Margot;
Tétart, Florence;
Carvalho, Priscille;
Bauvin, Olivia;
Hervouet, Charles;
Joly, Pascal;
Hébert, Vivien

Publication type:

Article

Longitudinal Pathogenic Properties and N -Glycosylation Profile of Antibodies from Patients with Pemphigus after Corticosteroid Treatment.

Published in:

Biomedicines, 2021, v. 9, n. 10, p. 1411, doi. 10.3390/biomedicines9101411

By:

Petit, Marie;
Walet-Balieu, Marie-Laure;
Schapman, Damien;
Golinski, Marie-Laure;
Burel, Carole;
Barray, Marion;
Drouot, Laurent;
Maho-Vaillant, Maud;
Hébert, Vivien;
Boyer, Olivier;
Bardor, Muriel;
Joly, Pascal;
Calbo, Sébastien

Publication type:

Article

Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid Regimen.

Published in:

Frontiers in Immunology, 2021, v. 12, p. N.PAG, doi. 10.3389/fimmu.2021.666022

By:

Hébert, Vivien;
Maho-Vaillant, Maud;
Golinski, Marie-Laure;
Petit, Marie;
Riou, Gaëtan;
Boyer, Olivier;
Musette, Philippe;
Calbo, Sébastien;
Joly, Pascal

Publication type:

Article

IgG N- glycosylation from Patients with Pemphigus Treated with Rituximab.

Published in:

Biomedicines, 2022, v. 10, n. 8, p. N.PAG, doi. 10.3390/biomedicines10081774

By:

Font, Guillaume;
Walet-Balieu, Marie-Laure;
Petit, Marie;
Burel, Carole;
Maho-Vaillant, Maud;
Hébert, Vivien;
Chan, Philippe;
Fréret, Manuel;
Boyer, Olivier;
Joly, Pascal;
Calbo, Sébastien;
Bardor, Muriel;
Golinski, Marie-Laure

Publication type:

Article

Ipilimumab-induced renal granulomatous arteritis: a case report.

Published in:

2019

By:

Lemoine, Mathilde;
Dilly, Baptiste;
Curie, Alexandre;
Hébert, Vivien;
Laurent, Charlotte;
Hanoy, Mélanie;
Grangé, Steven;
Guerrot, Dominique;
François, Arnaud;
Bertrand, Dominique

Publication type:

journal article

Optimizing Pemphigus Management With Rituximab and Short-Term Relapse Predictors.

Published in:

JAMA Dermatology, 2025, v. 161, n. 4, p. 399, doi. 10.1001/jamadermatol.2024.6130

By:

Hébert, Vivien;
Hamwi, Sami;
Tancrède-Bohin, Emmanuelle;
Quéreux, Gaelle;
Pham-Ledard, Anne;
Caux, Frédéric;
Tedbirt, Billal;
Lefebvre, Alexis;
Cordel, Nadège;
Alexandre, Marina;
Viguier, Manuelle;
Jeudy, Géraldine;
D'Incan, Michel;
Debarbieux, Sébastien;
Brue, Alexis;
Duvert-Lehembre, Sophie;
Fenot, Marion;
Seta, Vannina;
Ingen-Housz-Oro, Saskia;
Lepelletier, Clémence

Publication type:

Article

Evaluation of Clinical Relevance and Biological Effects of Antirituximab Antibodies in Patients With Pemphigus.

Published in:

2022

By:

Lemieux, Alexandre;
Maho-Vaillant, Maud;
Golinski, Marie-Laure;
Hébert, Vivien;
Boyer, Olivier;
Calbo, Sébastien;
Candon, Sophie;
Joly, Pascal

Publication type:

journal article

Mixed Individual-Aggregate Data on All-Cause Mortality in Bullous Pemphigoid: A Meta-analysis.

Published in:

2021

By:

Tedbirt, Billal;
Gillibert, André;
Andrieu, Emilie;
Hébert, Vivien;
Bastos, Sarah;
Korman, Neil J.;
Tang, Mark B. Y.;
Li, Jun;
Borradori, Luca;
Cortés, Begonia;
Kim, Soo-Chan;
Gual, Adrià;
Xiao, Ting;
Wieland, Carilyn N.;
Fairley, Janet A.;
Ezzedine, Khaled;
Joly, Pascal

Publication type:

journal article

Prevalence and pathogenic activity of anti-desmocollin-3 antibodies in patients with pemphigus vulgaris and pemphigus foliaceus.

Published in:

British Journal of Dermatology, 2025, v. 192, n. 6, p. 1072, doi. 10.1093/bjd/ljaf021

By:

Maho-Vaillant, Maud;
Lemieux, Alexandre;
Arnoult, Christophe;
Lebourgeois, Léopoldine;
Hébert, Vivien;
Jaworski, Thara;
Tedbirt, Billal;
Jouen, Fabienne;
Boyer, Olivier;
Calbo, Sébastien;
Joly, Pascal;
Golinski, Marie-Laure

Publication type:

Article

The emergence of circulating activated autoreactive desmoglein 3-specific follicular regulatory T cells is associated with long-term efficacy of rituximab in patients with pemphigus vulgaris.

Published in:

British Journal of Dermatology, 2024, v. 191, n. 4, p. 605, doi. 10.1093/bjd/ljae220

By:

Hébert, Vivien;
Novarino, Julien;
Maho-Vaillant, Maud;
Perals, Corine;
Calbo, Sébastien;
Golinski, Marie-Laure;
Martinez, Fanny;
Joly, Pascal;
Fazilleau, Nicolas

Publication type:

Article

The Diversity of Serum Anti-DSG3 IgG Subclasses Has a Major Impact on Pemphigus Activity and Is Predictive of Relapses After Treatment With Rituximab.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.849790

By:

Golinski, Marie-Laure;
Lemieux, Alexandre;
Maho-Vaillant, Maud;
Barray, Marion;
Drouot, Laurent;
Schapman, Damien;
Petit, Marie;
Hertl, Michael;
Boyer, Olivier;
Calbo, Sébastien;
Joly, Pascal;
Hébert, Vivien

Publication type:

Article

Long‐term real costs of a strategy using rituximab as first‐line treatment for patients with moderate‐to‐severe pemphigus: Evaluation from the French healthcare system.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2025, v. 39, n. 6, p. e524, doi. 10.1111/jdv.20497

By:

Tedbirt, Billal;
De Mulder, Hermance;
Joly, Pascal;
Lacroix, Elie;
Hébert, Vivien

Publication type:

Article